epithalon peptide protocol dosage - Pure Tested Peptides Epithalon - Unit Peptides –

The arginine salt form of BPC-157 is generally considered to have enhanced stability in liquid form compared to the standard acetate salt

The FDA placed it on a Category 2 do-not-compound list in 2023 over impurity and immune-reaction concerns, so no licensed compounding pharmacy can prepare it either

A 6-8 week escalation period between dose increases (instead of 4 weeks) is common in patients over 65

In short-bowel syndrome escalating throughout 4 weeks, the constant weight gain above preoperative values started immediately with peroral and parental BPC 157 therapy and the villus height, crypth depth and muscle thickness (inner (circular) muscular layer) additionally increased[3]

A compromised gut barrier is both a cause and a consequence of dysbiosis, and intervening at the level of mucosal integrity, which is precisely what BPC-157 does in animal models, represents a mechanistically coherent approach to gut-mediated systemic aging

Store unreconstituted vials at -20C for long-term, or refrigerated at 2-8C for short-term use